GLAXOSMITHKLINE (Cervarix)

ABOUT THE BRAND

GSK plc, is a multination pharmaceutical company that has its headquarters in London, England. Primarily a British group, it was established via merger of the Glaxo Wellcome and SMithKline Beecham, and was the sixth largest pharmaceutical company as of 2019 according to Forbes. The company is known to be the first developer of the malaria vaccine, and their legacy products include several that are listed in the World Health Organization’s list of essential medicines; these include amoxicillin, pyrimethamine, zidovudine, and mercaptopurine.    

One of the products in their vast portfolio is Cervarix. It is a vaccine that is intended for use on female patients aged 9 to 25 years old, and it is able to prevent various kinds of cancer of the vulva, cervix, and vagina that are caused by HPV types 16 and 18. The medication is able to allow the immune system to quickly analyze and detect the L1 proteins that make up the shell or capsid of the virus if the patient is infected, thereby allowing for faster immune responses, and leading to lesser symptoms. This also has the ability to help prevent the aforementioned types of cancers caused by HPV, as both real life and clinical study cases have shown. 

Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.